Veracyte's average Accounts Receivable for the
three
months ended in Mar. 2024 was $43.5 Mil. Veracyte's Revenue for the
three
months ended in Mar. 2024 was $96.8 Mil.
Hence, Veracyte's Days Sales Outstanding for the
three
months ended in Mar. 2024 was 41.01.
The historical rank and industry rank for Veracyte's Days Sales Outstanding or its related term are showing as below:
VCYT'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 20.04 Med: 49.55 Max: 58.7
Current: 41.64
During the past 13 years, Veracyte's highest Days Sales Outstanding was 58.70. The lowest was 20.04. And the median was 49.55.
VCYT's Days Sales Outstanding is ranked better than 82.88% of 222
companies
in the Medical Diagnostics & Research industry
Industry Median: 69.345
vs VCYT: 41.64
Veracyte's Days Sales Outstanding
declined
from Mar. 2023 (49.55) to Mar. 2024 (41.01).
Veracyte Days Sales Outstanding Historical Data
The historical data trend for Veracyte's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Veracyte's Days Sales Outstanding
For the Diagnostics & Research subindustry, Veracyte's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veracyte's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Veracyte's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Veracyte's Days Sales Outstanding falls into.
Veracyte Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veracyte (NAS:VCYT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Veracyte Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Veracyte's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. The company derives its revenues from the Sale of Afirma analysis products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VCYT has been successfully added to your 